disease_type,primary_site,submitter_id,age_at_index,race,gender,age_at_diagnosis,days_to_birth,pathologic_stage,pathologic_t,staging,tumor_class,primary_disease,primary_diagnosis,site_biopsy,specific_site,tissue_organ_origin,theraputic_agents,treatment_or_therapy,treatement_type,survival_1,days_to_death
2,2,TCGA-05-5429,60.0,5,2,22066.0,-22066.0,12,1,3,1,3,3,3,2,9,1,3,1,1,275.0
1,1,TCGA-2L-AAQA,76.0,1,2,28074.0,-28074.0,1,1,3,1,1,1,1,1,1,1,1,1,1,143.0
1,1,TCGA-2J-AABR,60.0,1,1,22131.0,-22131.0,3,1,3,1,1,1,1,5,18,1,2,3,1,
2,2,TCGA-05-4397,65.0,5,2,23833.0,-23833.0,1,5,5,1,3,14,3,2,37,1,5,10,2,731.0
1,1,TCGA-2L-AAQI,66.0,1,2,24381.0,-24381.0,1,1,3,1,1,1,1,1,3,2,2,5,1,103.0
2,2,TCGA-05-4244,70.0,5,2,25752.0,-25752.0,4,5,1,1,3,3,3,10,34,1,5,10,2,
2,2,TCGA-05-4389,70.0,5,2,25660.0,-25660.0,5,3,5,1,3,14,3,2,33,1,1,1,1,
